People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CoMentis Inc | — | Pharmaceuticals | Series A | $4.5M | $139.4M | 2016 |
Terence Kelly, PhD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Terence Kelly, PhD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Fred G. Middleton | 1 | 2 |
| John L. Higgins | 1 | 2 |
| Michael Detke, MD, PhD | 1 | 1 |
| Robert G. McNeil, PhD | 1 | 1 |
| Daniel L. Hunt | 1 | 1 |
| Dennis Henner, PhD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.